Bisacodyl

Bisacodyl Basic information
Product Name:Bisacodyl
Synonyms:2-(4,4’-diacetoxydiphenylmethyl)pyridine;2-(4,4'-Diacetoxydiphenylmethyl)pyridine;4,4'-(2-Pyridylmethylene)diphenol diacetate;4,4'-(2-Pyridylmethylene)diphenol diacetate (ester);4,4’-(2-pyridinylmethylene)bis-phenodiacetate(ester);4,4’-(2-pyridylmethylene)di-phenodiacetate(ester);4,4’-(2-pyridylmethylene)-diphenolacetate;4,4’-(2-Pyridylmethylene)-diphenolace-tate
CAS:603-50-9
MF:C22H19NO4
MW:361.39
EINECS:210-044-4
Product Categories:Inhibitors;API;Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Pharmaceuticals;DULCOLAX;603-50-9
Mol File:603-50-9.mol
Bisacodyl Structure
Bisacodyl Chemical Properties
Melting point 138°C
Boiling point 493.21°C (rough estimate)
density 1.2545 (rough estimate)
refractive index 1.5614 (estimate)
storage temp. Sealed in dry,2-8°C
solubility Practically insoluble in water, soluble in acetone, sparingly soluble in ethanol (96 per cent). It dissolves in dilute mineral acids.
pka4.69±0.10(Predicted)
form neat
color White to Off-White
Water Solubility Soluble in alcohol (slightly), ether (slightly), chloroform, and acetone. Insoluble in water.
λmax220nm(MeOH)(lit.)
Merck 14,1242
Stability:Stable. Incompatible with strong oxidizing agents.
InChIKeyKHOITXIGCFIULA-UHFFFAOYSA-N
LogP3.453 (est)
CAS DataBase Reference603-50-9(CAS DataBase Reference)
NIST Chemistry ReferenceBisacodyl(603-50-9)
EPA Substance Registry SystemPhenol, 4,4'-(2-pyridinylmethylene)bis-, diacetate (ester) (603-50-9)
Safety Information
Hazard Codes Xi
Risk Statements 22-36/37/38
Safety Statements 26-36
WGK Germany 3
RTECS SM8750000
TSCA Yes
HS Code 2933399090
Hazardous Substances Data603-50-9(Hazardous Substances Data)
ToxicityLD50 orally in rats: >3 g/kg (Schmidt)
MSDS Information
Bisacodyl Usage And Synthesis
Chemical PropertiesCrystalline Solid
OriginatorDulcolax,Boehringer Ingelheim,US,1958
UsesCathartic.
UsesStimulant laxative.
UsesBisacodyl is used in the inhibition of (Na+K)ATPase, the increase of mucosal PGE2, and the activation of adenyl cyclase in rat intestine studies. It is used as a laxative drug. It is typically prescribed for relief of constipation.
DefinitionChEBI: Bisacodyl is a diarylmethane.
Manufacturing ProcessPreparation of (4,4'-Dihydroxy-Diphenyl)-(Pyridyl-2)-Methane 70.0 grams of α-pyridine aldehyde are fed portionwise with stirring and cooling to a mixture of 200 grams of phenol and 100 cc of concentrated sulfuric acid. The reaction mixture is allowed to stand for a while with repeated stirring, whereby it becomes syrupy, neutralized with sodium carbonate, dissolved in methanol and filtered. The filtrate is introduced into a large quantity of water and the resulting precipitate is recrystallized from a methanol/water mixture. Colorless crystals are obtained of MP 254°C. When using zinc chloride or tin tetrachloride and warming to a temperature of about 50°C, a corresponding result is obtained.
Preparation of Bisacodyl: 5 grams of (4,4'-dihydroxy-diphenyl)-(pyridyl-2)- methane are heated with 5 grams of anhydrous sodium acetate and 20 cc of acetic anhydride for three hours over a boiling water bath. The cooled reaction mixture is poured into water, whereby after a while a colorless substance precipitates, which is filtered off with suction, washed with water and recrystallized from aqueous ethanol. Colorless bright crystals, MP 138°C are obtained.
Brand nameCorrectol Tablets, Caplets (Schering-Plough HealthCare); Dulcolax (Boehringer Ingelheim); Evac-Q-Tabs (Savage); Feen-a- Mint Tablets (Schering-Plough HealthCare); Modane (Savage); SK-Bisacodyl (SmithKline Beecham); Theralax (SmithKline Beecham).
Therapeutic FunctionLaxative
Clinical UseLaxative
Veterinary Drugs and TreatmentsBisacodyl oral and rectal products are used as stimulant cathartics in dogs and cats.
MetabolismBisacodyl is rapidly hydrolysed to the active principle bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), mainly by esterases of the enteric mucosa. After oral and rectal administration, only small amounts of the drug are absorbed and are almost completely conjugated in the intestinal wall and the liver to form the inactive BHPM glucuronide. Following the administration of bisacodyl coated tablets, an average of 51.8% of the dose was recovered in the faeces as free BHPM and an average of 10.5% of the dose was recovered in the urine as BHPM glucuronide. Following the administration as a suppository, an average of 3.1% of the dose was recoveredas BHPM glucuronide in the urine. Stool contained large amounts of BHPM (90% of the total excretion) in addition to small amounts of unchanged bisacodyl
Pralmorelin Sodium acetate CARBINOXAMINE DIPHENYLDISULFONATE 2-Chloro-5-chloromethylpyridine ETHYLENEDIAMINE TETRAKIS(PROPOXYLATE-BLOCK-ETHOXYLATE) TETROL Diphenolic acid 4-(Diethylamino)salicylaldehyde POLY(VINYL ACETATE) 4-Methylpyridine Cellulose acetate Bisphenol A 5-Chlorovaleric acid 2,4,6-Collidine ACETATE Ethyl acetate Glatiramer acetate Vinyl acetate Ammonium acetate

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.